Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex dosing in bariatric surgery
NCT01570179Phase 3Completed
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- May 2012
- Primary completion
- Jul 2012
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by CHRU de Nancy - Hôpital Central. Started May 2012; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT01570179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01570179.